1,232
Views
16
CrossRef citations to date
0
Altmetric
Review Articles

Review of clinical practice guidelines on the use of procalcitonin in infections

ORCID Icon, , , &
Pages 227-234 | Received 06 Sep 2019, Accepted 09 Dec 2019, Published online: 20 Dec 2019

References

  • Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34(4):263–273.
  • Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–518.
  • Tan M, Lu Y, Jiang H, et al. The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: a systematic review and meta-analysis. J Cell Biochem. 2019;120(4):5852–5859.
  • Huang HB, Peng JM, Weng L, et al. Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis. Ann Intensive Care. 2017;7(1):114.
  • Schuetz P, Wirz Y, Mueller B. Procalcitonin testing to guide antibiotic therapy in acute upper and lower respiratory tract infections. JAMA. 2018;319(9):925–926.
  • Trásy D, Tánczos K, Németh M, et al. Delta procalcitonin is a better indicator of infection than absolute procalcitonin values in critically ill patients: a prospective observational study. J Immunol Res. 2016;2016:1–9.
  • Jaeschke R, Guyatt GH, Schünemann H. Ten things you should consider before you believe a clinical practice guideline. Intensive Care Med. 2015;41(7):1340–1342.
  • National Institute for Health and Care Excellence (NICE). 2018. Developing NICE guidelines: the manual. [cited 2019 Nov 27]. Available from: https://www.nice.org.uk/process/pmg20/chapter/introduction-and-overview
  • Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552.
  • Lopardo G, Basombrío A, Clara L, et al. Guidelines for management of community-acquired pneumonia in adults. Medicina (B Aires). 2015;75:245–257.
  • Kochanek M, Schalk E, von Bergwelt-Baildon M, et al. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2019;98(5):1051–1069.
  • Höffken G, Lorenz J, Kern W, et al. Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the management of lower respiratory tract infections and community-acquired pneumonia. Pneumologie. 2010;64:149–154.
  • Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427–431.
  • Morrow BM, Argent AC, Jeena PM, et al. Guideline for the diagnosis, prevention and treatment of paediatric ventilator-associated pneumonia. S Afr Med J. 2009;99(4 Pt 2):255–267.
  • Gupta D, Agarwal R, Aggarwal AN, et al. Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: joint ICS/NCCP(I) recommendations. Lung India. 2012;29(6):27–62.
  • Vogelmeier C, Buhl R, Burghuber O, et al. Guideline for the diagnosis and treatment of COPD patients – issued by the German Respiratory Society and the German Atemwegsliga in cooperation with the Austrian Society of Pneumology. Pneumologie. 2018;72:253–308.
  • Stuck BA, Beule A, Jobst D, et al. Guideline for “rhinosinusitis”-long version: S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery. HNO. 2018;66(1):38–74.
  • Reinhart K, Brunkhorst FM, Bone HG, et al. Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI). Anaesthesist. 2010;59(4):347–370.
  • National Institute for Health and Care Excellence (NICE) 2015. Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay). ISBN: 978-14731-1463-0. [cited 2019 Nov 27]. Available from: https://www.nice.org.uk/guidance/dg18
  • Working Group of the Clinical Practice Guideline on the Management of Invasive Meningococcal Disease. [cited 2019 Nov 27]. Available from: https://www.guidelinecentral.com/summaries/clinical-practice-guideline-on-the-management-of-invasive-meningococcal-disease/
  • Management of Chronic Obstructive Pulmonary Disease Working Group. VA/DoD clinical practice guideline for the management of chronic obstructive pulmonary disease. [cited 2019 Nov 27]. Available from: https://www.guidelinecentral.com/summaries/vadod-clinical-practice-guideline-for-the-management-of-chronic-obstructive-pulmonary-disease/#section-society
  • Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111.
  • Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51–e77.
  • Tunkel AR, Hasbun R, Bhimraj A, et al. Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):e34–e65.
  • Sepsis (adults). Current Care Guidelines. Working group set up by the Finnish Medical Society Duodecim and the Finnish Society of Anaesthesiologists. Helsinki: The Finnish Medical Society Duodecim; 2015. [cited 2019 Nov 27]. Available from: www.kaypahoito.fi
  • de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomized, controlled, open-label trial. Lancet Infect Dis. 2016;16(7):819–827.
  • Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95–107.
  • Sager R, Kutz A, Mueller B, et al. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med. 2017;15(1):15.
  • Zil-E-Ali A, Naqvi S, Tariq M. Procalcitonin: a powerful rescuer on surgical floors. Cureus. 2017;9(7):e1446.
  • Tujula B, Kokki H, Räsänen J, et al. Procalcitonin; a feasible biomarker for severe bacterial infections in obstetrics and gynecology? Acta Obstet Gynecol Scand. 2018;97(5):505–506.
  • Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019;57(9):1308–1318.
  • US Food and Drug Administration. FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis. [cited 2019 Nov 27]. Available from: https://www.fda.gov/news-events/press-announcements/fda-clears-test-help-manage-antibiotic-treatment-lower-respiratory-tract-infections-and-sepsis
  • US Food and Drug Administration. 510(k) substantial equivalence determination decision summary assay and instrument combination template. [cited 2019 Nov 27]. Available from: https://www.accessdata.fda.gov/cdrh_docs/reviews/K071146.pdf
  • Baron DM, Metnitz PGH, Rhodes A, et al. Clinical guidelines: how can we improve andherence and implementation? Eur J Anaesthesiol. 2017;34(6):329–331.
  • Levy MM, Rhodes A, Phillips GS, et al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med. 2014;40(11):1623–1633.
  • Huang DT, Yealy DM, Filbin MR, et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med. 2018;379(3):236–249.
  • Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171(15):1322–1331.
  • Tujula B, Kokki M, Pulkki K, et al. The usage of procalcitonin in Finland. Acta Anaesthesiol Scand. 2018;62(8):1092–1097.
  • Hohn A, Balfer N, Heising B, et al. Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock. Ann Intensive Care. 2018;8(1):68.
  • Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38(2):367–374.
  • Fernández Mondéjar E. Considerations on the low adherence to clinical practice guidelines. Med Intesiva. 2017;41(5):265–266.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.